Content
01/07/2025
Nashville, TN USA
Evergreen Nephrology
completed $130 million Venture Round funding. Investors include
Rubicon Founders (lead), Oak HC/FT (lead), K2 HealthVentures.
About
Evergreen Nephrology partners with nephrologists and payors to redefine kidney care for patients with chronic and end-stage kidney disease. Operating across 24 states with a network of over 900 providers, Evergreen delivers personalized, value-based care designed to empower patients and improve outcomes.
Startup
Sector:
Healthcare
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
